Literature DB >> 24895151

P1PK, GLOB, and FORS blood group systems and GLOB collection: biochemical and clinical aspects. Do we understand it all yet?

Radoslaw Kaczmarek1, Anna Buczkowska2, Katarzyna Mikołajewicz1, Hubert Krotkiewski1, Marcin Czerwinski3.   

Abstract

Antigens belonging to the P1PK, GLOB, and FORS blood group systems and the GLOB blood group collection represent a closely related set of 13 glycosphingolipids (GSLs). They are synthesized by the coordinated action of glycosyltransferases, encoded by at least 7 different loci. Three of these enzymes show either different activity or a different mRNA expression profile due to genetic polymorphisms, resulting in blood group diversity. In recent years, significant progress has been made in understanding the molecular background and biological functions of these GSLs. Their medical significance is often related to the existence of natural antibodies, as they may cause complications after transfusions and during pregnancies. In addition, GSLs belonging to these blood group systems are receptors for several pathogens. This review summarizes the present knowledge about the complicated network of enzymatic interactions leading to synthesis of these GSLs, as well as their clinical implications.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FORS; GLOB; Glycosphingolipids; NOR; P(1)/P(2); P1PK

Mesh:

Substances:

Year:  2014        PMID: 24895151     DOI: 10.1016/j.tmrv.2014.04.007

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  9 in total

Review 1.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase.

Authors:  Radoslaw Kaczmarek; Katarzyna Mikolajewicz; Katarzyna Szymczak; Maria Duk; Edyta Majorczyk; Anna Krop-Watorek; Anna Buczkowska; Marcin Czerwinski
Journal:  Glycoconj J       Date:  2016-08-18       Impact factor: 2.916

Review 3.  CD1: A Singed Cat of the Three Antigen Presentation Systems.

Authors:  Radoslaw Kaczmarek; Mariola Pasciak; Katarzyna Szymczak-Kulus; Marcin Czerwinski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-04-06       Impact factor: 4.291

4.  ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.

Authors:  Céline Montavon Sartorius; Andreas Schoetzau; Henriette Kettelhack; Daniel Fink; Neville F Hacker; André Fedier; Francis Jacob; Viola Heinzelmann-Schwarz
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

5.  Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system.

Authors:  Radoslaw Kaczmarek; Katarzyna Szymczak-Kulus; Anna Bereźnicka; Krzysztof Mikołajczyk; Maria Duk; Edyta Majorczyk; Anna Krop-Watorek; Elżbieta Klausa; Joanna Skowrońska; Bogumiła Michalewska; Ewa Brojer; Marcin Czerwinski
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

Review 6.  Advances in the Development of Antiviral Strategies against Parvovirus B19.

Authors:  Elisabetta Manaresi; Giorgio Gallinella
Journal:  Viruses       Date:  2019-07-18       Impact factor: 5.048

Review 7.  Microbial lectome versus host glycolipidome: How pathogens exploit glycosphingolipids to invade, dupe or kill.

Authors:  Anna Bereznicka; Krzysztof Mikolajczyk; Marcin Czerwinski; Radoslaw Kaczmarek
Journal:  Front Microbiol       Date:  2022-08-19       Impact factor: 6.064

8.  The synonymous 903C>G mutation in the alpha 1,4-galactosyltransferase gene in a Chinese woman with habitual abortion: A case report.

Authors:  Xiaoying Lv; Yongquan Chen; Yuanyuan Luo; Lingbo Li; Houzhao Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 9.  Histo-blood group glycans in the context of personalized medicine.

Authors:  Viktoria Dotz; Manfred Wuhrer
Journal:  Biochim Biophys Acta       Date:  2015-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.